[Single-lung transplantation for end-stage pulmonary parenchymal diseases with pulmonary hypertension].
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue
; 19(7): 401-3, 2007 Jul.
Article
en Zh
| MEDLINE
| ID: mdl-17631705
ABSTRACT
OBJECTIVE:
To observe the outcome of single-lung transplantation (SLT) for end-stage pulmonary parenchymal diseases in combination with pulmonary hypertension (PH).METHODS:
From September 2002 to November 2005, there were 22 lung transplantation recipients, suffering from emphysema (10/22), pulmonary fibrosis (10/22), pneumosilicosis (1/22) and vascular leiomyoma (1/22), and all of them were complicated with pulmonary hypertension to different extent. Operative techniques 10 patients received left-lung transplantations, and 12 patients received right-lung transplantation. In all the patients echocardiography (ECHO) was performed before transplantation, and arterial blood was collected to determine oxygenation index (PaO(2)/FiO(2)).RESULTS:
The systolic pulmonary artery pressure (Ppa, syst) was monitored by Swan-Gans catheterization one week post-transplantation, and it was found to have decreased significantly [from (50.00+/-13.00) mm Hg (1 mm Hg=0.133 kPa) to (39.5+/-7.36) mm Hg,P<0.05]. Simultaneously, PaO(2)/FiO(2) was improved [from (241.26+/-79.54) mm Hg to (348.23+/-99.31) mm Hg, P<0.05].CONCLUSION:
Single lung transplantation is an efficient way to deal with end-stage pulmonary parenchymal disease combined with pulmonary hypertension.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Trasplante de Pulmón
/
Hipertensión Pulmonar
/
Enfermedades Pulmonares
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Zh
Año:
2007
Tipo del documento:
Article